UK markets open in 2 hours 31 minutes

BioInvent International AB (publ) (0H22.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
44.540.00 (0.00%)
At close: 05:13PM BST
Currency in SEK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.33
52-week change 3-39.89%
S&P500 52-week change 323.42%
52-week high 344.54
52-week low 314.60
50-day moving average 316.57
200-day moving average 316.97

Share statistics

Avg vol (3-month) 31.19k
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 834.14M
% held by insiders 113.36%
% held by institutions 154.16%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.04:1
Last split date 314 Dec 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 0.00%
Operating margin (ttm)-728.14%

Management effectiveness

Return on assets (ttm)-14.88%
Return on equity (ttm)-22.66%

Income statement

Revenue (ttm)71.46M
Revenue per share (ttm)1.09
Quarterly revenue growth (yoy)-25.80%
Gross profit (ttm)N/A
EBITDA -361.29M
Net income avi to common (ttm)-330.3M
Diluted EPS (ttm)-4.55
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.07B
Total cash per share (mrq)16.24
Total debt (mrq)23.24M
Total debt/equity (mrq)1.78%
Current ratio (mrq)14.93
Book value per share (mrq)19.90

Cash flow statement

Operating cash flow (ttm)-341.69M
Levered free cash flow (ttm)-235.5M